Loren Ann C. Carino

Loren Ann Carino practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Loren Ann Carino's NPI, 1760903512, was assigned on July 2, 2017. Loren Ann Carino holds California license 95008748.

Loren Ann Carino's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Loren Ann Carino's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Loren Ann Carino is also affiliated with Torrance Memorial Medical Center. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Loren Ann Carino to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Loren Ann Carino practices, 3 sites in all. Vendor and product names are available with a free account.

Acute care is Loren Ann Carino's primary specialty in the NPI Registry, under taxonomy code 363LA2100X. Loren Ann Carino is licensed in California.

Dmand AI lists chronic diabetes among the conditions Loren Ann Carino treats.

CMS data shows 71 Medicare services from Loren Ann Carino across 1 procedure code in 2024, all of them office visits, for 41 Medicare patients. Medicare paid $4,830 for them. Every service was in an office.

CMS counts 41 Medicare patients who saw Loren Ann Carino in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 63% are also on Medicaid. Their average risk score is 4.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Loren Ann Carino's median patient age at 67, with 43% women.

In 2024, Loren Ann Carino wrote 636 Medicare Part D claims for 89 patients. 84% of them were for generic drugs. CMS names the drug for 492 of them, across 20 drugs with 11 or more claims each, at $93,232 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Loren Ann Carino for performance year 2024, reported as part of a group. Loren Ann Carino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Loren Ann Carino as offering telehealth.

CMS Open Payments shows 6 general payments to Loren Ann Carino from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $185.